|
Report Date : |
18.06.2012 |
IDENTIFICATION DETAILS
|
Name : |
CHROMO LABORATORIES INDIA PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
20-41/60/104, Flat No. 104, Mathrusri Homes, Miyapur, X Roads,
Serilingampalli Mandal, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as
on) : |
31.03.2011 |
|
|
|
|
Date of
Incorporation : |
26.06.2006 |
|
|
|
|
Com. Reg. No.: |
01-050452 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs. 19.624 Millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24231AP2006PTC050452 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
HYDC03424B |
|
|
|
|
PAN No.: [Permanent Account No.] |
AACCC8549H |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business
: |
Manufacturer of Intermediates and Active Pharmaceutical Ingredients. |
|
|
|
|
No. of Employees
: |
Not Available |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba (44) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 100000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually Correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an established company having satisfactory track. Trade
relations are reported as fair. Business is active. Payments are reported to be
usually correct and as per commitments. The company can be considered normal for business dealings at usual
trade terms and conditions. |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
|
A1 |
A1 |
|
|
|
|
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
LOCATIONS
|
Registered / Corporate Office : |
20-41/60/104, Flat No. 104, Mathrusri Homes, Miyapur, X Roads,
Serilingampalli Mandal, |
|
Tel. No.: |
91-40-32002164 |
|
Fax No.: |
Not Available |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Factory : |
Plot No. 43&44, Phase II, IDA Pashamylaram, Patancheru Mandal,
District Medak, Hyderabad – 502307, Andhra Pradesh, India |
|
Tel. No.: |
91-8455-224145 |
|
Fax No.: |
91-8455-224145 |
|
Alt No.: |
91-40-32002164 |
|
E-Mail : |
DIRECTORS
(AS ON 30.09.2011)
|
Name : |
Mr. Ananda Reddy Bomma |
|
Designation : |
Managing Director |
|
Address : |
H. No. 1-2-33/21/7/1-A, A S Raju Nagar, Nizampat Road,
Kolunuraghavareddy Function Hall Beside Road, Hyderabad, Andhra Pradesh,
India |
|
Date of Birth/Age : |
06.05.1972 |
|
Date of Appointment : |
26.06.2006 |
|
DIN No.: |
01650110 |
Other Directorship :
|
S.No. |
CIN/LLPIN |
Name
of the Company/ LLP |
Current
designation of the Director/ Designated Partner |
Date
of appointment at current designation |
Original
date of appointment |
Date
of cessation |
Company/
LLP Status |
Defaulting
status |
|
1 |
U24230AP2004PTC044953 |
GENSYNTH FINE
CHEMIALS PRIVATE LIMITED |
Managing
director |
23-12-04 |
23-12-04 |
- |
Active |
NO |
|
2 |
U24231AP2006PTC050452 |
CHROMO
LABORATORIES INDIA PRIVATE LIMITED |
Managing
director |
26-06-06 |
26-06-06 |
- |
Active |
NO |
|
3 |
U24232AP2009PTC066044 |
GENSYNTH PHARMA
PRIVATE LIMITED |
Director |
01-12-09 |
01-12-09 |
- |
Active |
NO |
|
4 |
U73100AP2010PTC069122 |
CHROMO
ANALYTICAL SERVICES PRIVATE LIMITED |
Director |
24-06-10 |
24-06-10 |
- |
Active |
NO |
|
5 |
U31300AP2005PTC047085 |
KHANTI CABLES
PRIVATE LIMITED |
Director |
18-03-11 |
18-03-11 |
15-06-11 |
Active |
NO |
|
6 |
U24232AP2011PTC074115 |
CHROMO HEALTH
CARE PRIVATE LIMITED |
Director |
27-04-11 |
27-04-11 |
- |
Active |
NO |
|
|
|
|
Name : |
Mr. Srirami Reddy Bhimavarapu |
|
Designation : |
Director |
|
Address : |
H. No: 2-125/1/3/A, Sri Datta Sai Colony, Gangaram, |
|
Date of Birth/Age : |
14.08.1971 |
|
Date of Appointment : |
26.06.2006 |
|
DIN No.: |
01768703 |
Other Directorship :
|
S.No. |
CIN/LLPIN |
Name
of the Company/ LLP |
Current
designation of the Director/ Designated Partner |
Date
of appointment at current designation |
Original
date of appointment |
Company/
LLP Status |
Defaulting
status |
|
1 |
U24230AP2004PTC044953 |
GENSYNTH FINE
CHEMIALS PRIVATE LIMITED |
Director |
23-12-04 |
23-12-04 |
Active |
NO |
|
2 |
U24231AP2006PTC050452 |
CHROMO
LABORATORIES INDIA PRIVATE LIMITED |
Director |
26-06-06 |
26-06-06 |
Active |
NO |
|
3 |
U24232AP2009PTC066044 |
GENSYNTH PHARMA
PRIVATE LIMITED |
Director |
01-12-09 |
01-12-09 |
Active |
NO |
|
|
|
|
Name : |
Mr. Chandrasekhara Naidu Gangapalli |
|
Designation : |
Director |
|
Address : |
LIG 531, Bharathi Nagar, R C Puram, Medak District, |
|
Date of Birth/Age : |
07.06.1968 |
|
Date of Appointment : |
26.06.2006 |
|
DIN No.: |
01763440 |
|
Name : |
Mr. Penumatsa Dhana Satyanarayana Raju |
|
Designation : |
Director |
|
Address : |
Plot No. 569, Vasantha Nagar Colony, KPHB, Kukatpally, |
|
Date of Birth/Age : |
22.04.1970 |
|
Date of Appointment : |
26.06.2006 |
|
DIN No.: |
02414693 |
|
|
|
Other Directorship :
|
S.No. |
CIN/LLPIN |
Name
of the Company/ LLP |
Current
designation of the Director/ Designated Partner |
Date
of appointment at current designation |
Original
date of appointment |
Company/
LLP Status |
Defaulting
status |
|
1 |
U24231AP2006PTC050452 |
CHROMO
LABORATORIES INDIA PRIVATE LIMITED |
Director |
26-06-06 |
26-06-06 |
Active |
NO |
|
2 |
U24232AP2009PTC066044 |
GENSYNTH PHARMA
PRIVATE LIMITED |
Director |
01-12-09 |
01-12-09 |
Active |
NO |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
(AS ON 30.09.2011)
|
Names of Shareholders |
|
No. of Shares |
|
Ananda Reddy Bomma |
|
615200 |
|
Srirami Reddy Bhimavarapu |
|
331800 |
|
Chandrasekhara Naidu Gangapalli |
|
489100 |
|
Penumatsa Dhana Satyanarayana Raju |
|
331800 |
|
Prabhakar Varma Mudhiraju |
|
170500 |
|
Guntaka Suresh Reddy |
|
24000 |
|
Total |
|
1962400 |
(AS ON 30.09.2011)
|
Equity Share
Breakup |
|
Percentage of
Holding |
|
Category |
|
|
|
Directors or relatives of directors |
|
100.00 |
|
Total
|
|
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer of Intermediates and Active Pharmaceutical Ingredients. |
GENERAL INFORMATION
|
Customers : |
|
|||||||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||||||||
|
No. of Employees : |
Not Available |
|||||||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||||||||
|
Bankers : |
|
|||||||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||||||||
|
Facilities : |
|
|||||||||||||||||||||||||||||||||
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
M N Reddy and Company Chartered Accountants |
|
Address : |
B-41, Madhuranagar, Near S R Nagar,
X Roads, Beside |
|
Tel. No.: |
91-40-23709888 |
|
Mobile No.: |
91-9000992096 |
|
E-Mail : |
|
|
PAN No.: |
AAIFM5259K |
CAPITAL STRUCTURE
(AS ON 31.03.2011)
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
2500000 |
Equity Shares |
Rs.10/- each |
Rs. 25.000 Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
1962400 |
Equity Shares |
Rs.10/- each |
Rs. 19.624
Millions |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
19.624 |
19.624 |
13.000 |
|
|
2] Share Application Money |
0.000 |
0.000 |
1.220 |
|
|
3] Reserves & Surplus |
23.295 |
16.156 |
4.952 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
42.919 |
35.780 |
19.172 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
57.454 |
30.978 |
26.117 |
|
|
2] Unsecured Loans |
1.349 |
1.360 |
3.213 |
|
|
3] Creditors for
Capital Assets Purchases |
12.526 |
1.273 |
3.049 |
|
|
TOTAL BORROWING |
71.329 |
33.611 |
32.379 |
|
|
DEFERRED TAX LIABILITIES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
114.248 |
69.391 |
51.551 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
86.625 |
40.390 |
35.640 |
|
|
Capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
0.000 |
0.000 |
0.000 |
|
|
DEFERREX TAX ASSETS |
0.152 |
1.056 |
0.609 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
47.836
|
15.536 |
10.091 |
|
|
Sundry Debtors |
47.571
|
25.693 |
6.151 |
|
|
Cash & Bank Balances |
6.045
|
0.030 |
1.449 |
|
|
Other Current Assets |
9.461
|
8.145 |
6.468 |
|
|
Loans & Advances |
3.745
|
3.006 |
2.049 |
|
Total
Current Assets |
114.658
|
52.410 |
26.208 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditor |
82.647
|
10.620 |
6.340 |
|
|
Other Current Liabilities |
2.168
|
2.966 |
0.860 |
|
|
Provisions |
2.527
|
11.107 |
3.851 |
|
Total
Current Liabilities |
87.342
|
24.693 |
11.051 |
|
|
Net Current Assets |
27.316
|
27.717 |
15.157 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.155 |
0.228 |
0.145 |
|
|
|
|
|
|
|
|
TOTAL |
114.248 |
69.391 |
51.551 |
|
PROFIT & LOSS ACCOUNT
|
|
PARTICULARS |
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
|
|
TURNOVER AND
OTHER INCOME |
374.703 |
284.050 |
117.302 |
|
|
|
|
|
|
|
|
|
|
NET PROFIT AFTER
TAX (Including Deferred Tax) |
7.139 |
11.204 |
1.209 |
|
|
|
|
|
|
|
|
|
|
EARNINGS IN
FOREIGN CURRENCY |
|
|
|
|
|
|
|
Export Earnings |
15.304 |
14.311 |
2.955 |
|
|
TOTAL EARNINGS |
15.304 |
14.311 |
2.955 |
|
|
|
|
|
|
|
|
|
|
IMPORTS |
|
|
|
|
|
|
|
Raw Materials |
20.313 |
9.272 |
4.705 |
|
|
TOTAL IMPORTS |
20.313 |
9.272 |
4.705 |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
3.64 |
5.71 |
0.93 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
PAT / Total Income |
(%) |
1.91
|
3.94 |
1.03 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
3.70
|
1.63 |
2.27 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.31
|
2.12 |
2.37 |
LOCAL AGENCY FURTHER INFORMATION
|
Check list by info
Agents |
Available in Report (Yes/ No) |
|
Year of Establishment |
Yes |
|
Locality of the Firm |
Yes |
|
Constitution of the Firm |
Yes |
|
Premises details |
No |
|
Type of Business |
Yes |
|
Line of Business |
Yes |
|
Promoter’s Background |
Yes |
|
No. of Employees |
No |
|
Name of Person Contacted |
No |
|
Designation of Contact person |
No |
|
Turnover of Firm for last three years |
Yes |
|
Profitability for last three years |
Yes |
|
Reasons for variation <> 20% |
--------- |
|
Estimation for coming financial year |
No |
|
Capital in the business |
Yes |
|
Details of sister concerns |
No |
|
Major Suppliers |
No |
|
Major Customers |
No |
|
Payments Terms |
No |
|
Export/ Imports Details (If applicable) |
No |
|
Market Information |
------------- |
|
Litigations that the firm/ Promoters Involved in |
------------ |
|
Banking details |
Yes |
|
Banking Facility Details |
Yes |
|
Conduct of the Banking Account |
------------ |
|
Buyer visit details |
------------- |
|
Financials, if provided |
Yes |
|
Incorporation details is applicable |
Yes |
|
Last Accounts filed at ROC |
Yes |
|
Major Shareholders, if available |
Yes |
NOTE:
The company changed its registered office from Flat No 101 Mathrusri
Homes, Miyapur Cross Roads, Miyapur, Serilingampalli Mandal,
FINANCIAL
PERFORMANCE:
The Company’s
turnover and other income during the year under review were Rs. 374.703
Millions. The operations have resulted a Profit of Rs. 27.494 Millions before
depreciation, Interest & Income Tax and resulted a Net Profit of Rs. 7.139
Millions after taxes (including differed tax).
FORM 8
|
Corporate
identity number of the company |
U24231AP2006PTC050452 |
|
Name of the
company |
CHROMO
LABORATORIES INDIA PRIVATE LIMITED |
|
Address of the
registered office or of the principal place of business in |
20-41/60/104, Flat No. 104, Mathrusri Homes, Miyapur, X Roads,
Serilingampalli Mandal, |
|
This form is for |
Modification of
charge |
|
Charge
identification number of the modified |
10184424 |
|
Type of charge |
Immovable property Book Debts Movable Property (not being pledge) Others |
|
Particular of
charge holder |
Andhra Bank, R C
Puram Branch, R C Puram, Email: bmhydm455@andhrabank.co.in
|
|
Nature of
description of the instrument creating or modifying the charge |
1. Letter of
sanction for Term Loan, Open Cash Credit & F.L.C dated 28.03.2011 2. Composite
Agreement dated 29.03.2011 |
|
Date of
instrument Creating the charge |
29.03.2011 |
|
Amount secured by
the charge |
Rs. 104.000
Millions |
|
Brief particulars
of the principal terms an conditions and extent and operation of the charge |
Rate of Interest 1. On OCC : Base
Rate + Spread 3.50% = Presently 13.00% 2. FLC : As per
applicable for import FLCs. 3. On Term Loan :
Base Rate + 3.50%+0.25% = Presently 13.25% Terms of
Repayment 1. Open Cash
Credit : One year 2. FLC
(Usance) : 90 days 3. Term Loan : Repayable in 28 quarterly
installments with a gestation period of 12 months. Margin 1. Cash Credit -
25% on Inventory and 40% on Receivables 2. FLC - 15% Cash
Margin 3. Term Loan - 25% on Plant & Machinery and all
other items & 60% on Building. Extent and
Operation of the charge A) Open Cash
Credit of Rs. 20.000 Millions . Prime security is on Inventory and
Receivables. B) FLC – Rs.
6.000 Millions. Prime security is on hypothecation of material imported
against FLC C) Term Loan of
Rs. 39.000 Millions. Prime Security is Hypothecation of machinery proposed to
be purchased worth of Rs.44.391 Millions and EMD of proposed building worth
Rs.14.418 Millions. |
|
Short particulars
of the property charged |
Prime security is
on Stock and book debts, imported material, bills, Colleteral
Security is on Existing land of 2993 sq yards along with building situated at
Plot No. 43 & 44(Shed No.34, SNo.331&335) IDA, Phase II, Colleteral
Security is on Existing land of 1638.86 sq yards along with building situated
in S No. 248, Shed No.33, Plot No.43,
IDA, Phase II, Colleteral
Security is on Existing land of 2998.90 sq yards situated at S No. 248, Shed
No.31 & 32, IDA, Phase II, |
|
Particulars of
the present modification |
Sanctioning of
fresh term loan of Rs.39.000 Millions in addition to the existing term loan
of Rs.39.000 Millions, enhancement of OCC limit from 15.000 Millions to
20.000 Millions, FLC Rs.6.000 Millions. |
FIXED ASSETS:
AS PER WEBSITE DETAILS
PROFILE
Subject is a
DIRECTORS PROFILE
Mr. B.Ananda Reddy, Managing
Director.
Mr.Ananda Reddy
is the founder Director and holds a Masters degree in Science from
During his tenure
he had faced several USFDA inspections.
In 2004 he
ventured in to starting Gensynth Fine Chemicals Private Limited which is a
Visualising the
future potential for the Indian Pharmaceutical Ingredients in the Global
generics space, Gensynth Fine chemicals acquired a API manufacturing Unit i.e Subject in the year 2006 to realize the Generic -
API dream.
Over the last one
year he has been instrumental in transforming CHROMO LABORATORIES in to a cGMP
manufacturing unit conforming to Q7A and WHO guidelines.
B. Srirami Reddy - Director
Mr. Sri Rami
Reddy is one of the founder directors and has been one of the key architects in
developing the organization. He is a Graduate in Engineering and has
over 15 years working experience at Dr. Reddy’s Laboratories Limited in Engineering Services and projects.
Currently he
looks after designing, installing, and qualifying chemical and pharmaceutical
process equipment in addition to overall procurement of Plant and machinery.
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or investigation
registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority for
any financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws, regulations
or policies that prohibit, restrict or otherwise affect the terms and
conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs. 55.60 |
|
|
1 |
Rs. 87.34 |
|
Euro |
1 |
Rs. 70.66 |
INFORMATION DETAILS
|
Report Prepared
by : |
ACH |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
5 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
5 |
|
--PROFITABILIRY |
1~10 |
5 |
|
--LIQUIDITY |
1~10 |
5 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
5 |
|
--CREDIT LINES |
1~10 |
4 |
|
--MARGINS |
-5~5 |
- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
44 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.